Novel nanostructured lipid carrier co-loaded with doxorubicin and docosahexaenoic acid demonstrates enhanced in vitro activity and overcomes drug resistance in MCF-7/Adr cells.
about
Recent trends in the development of nanophytobioactive compounds and delivery systems for their possible role in reducing oxidative stress in Parkinson's disease modelsBiodegradable Janus nanoparticles for local pulmonary delivery of hydrophilic and hydrophobic molecules to the lungs.Octreotide-periplocymarin conjugate prodrug for improving targetability and anti-tumor efficiency: synthesis, in vitro and in vivo evaluation.Nanostructured lipid-carrageenan hybrid carriers (NLCCs) for controlled delivery of mitoxantrone hydrochloride to enhance anticancer activity bypassing the BCRP-mediated efflux.Improved pharmacokinetics and enhanced tumor growth inhibition using a nanostructured lipid carrier loaded with doxorubicin and modified with a layer-by-layer polyelectrolyte coating.Solid Lipid Nanoparticles: A Potential Multifunctional Approach towards Rheumatoid Arthritis Theranostics.Controlled and Targeted Drug Delivery by a UV-responsive Liposome for Overcoming Chemo-resistance in Non-Hodgkin Lymphoma.Hydrophobic ion pairing as a strategy to improve drug encapsulation into lipid nanocarriers for the cancer treatment.Nanostructured Lipid Carrier Co-loaded with Doxorubicin and Docosahexaenoic Acid as a Theranostic Agent: Evaluation of Biodistribution and Antitumor Activity in Experimental Model.Drug delivery to solid tumors: the predictive value of the multicellular tumor spheroid model for nanomedicine screening.Glioma targeted delivery strategy of doxorubicin-loaded liposomes by dual-ligand modification.Pluronic-attached polyamidoamine dendrimer conjugates overcome drug resistance in breast cancer.Sequential culture on biomimetic nanoclay scaffolds forms three-dimensional tumoroids.
P2860
Q26775886-664FA359-F49A-4714-9B06-E443F9246190Q34464430-8719676A-9FE1-4085-A049-E4D052F532C8Q37699239-696FD48F-509B-4127-80F9-5FD7F823C754Q38804702-B1713DD6-4CC3-43F1-9ED0-E4147879D96BQ38839118-5E1BE986-AE59-4851-BE7F-3E2D1C5A4AA4Q38862535-D5F3A246-62FA-4E00-8CF8-38E4A46A2ED9Q38903528-18AF1478-C9E3-4A1D-AD40-7163CCD94257Q39021928-0E1D887B-1DD3-4BC4-A8B5-F0DF0795A60BQ46209091-14ED0352-8577-4695-AE25-66F3D9884667Q46914962-69CE0F2A-03DB-449C-8DC7-0C53A5E511C1Q47933145-26B4454D-80FF-46D7-878B-C9E85C0B80C5Q51116307-6DBEC786-C7F2-4779-9BFA-C7987ADB4D0DQ51526062-6CC24637-C9DB-4D72-9C2D-4C098F579880
P2860
Novel nanostructured lipid carrier co-loaded with doxorubicin and docosahexaenoic acid demonstrates enhanced in vitro activity and overcomes drug resistance in MCF-7/Adr cells.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Novel nanostructured lipid car ...... resistance in MCF-7/Adr cells.
@en
Novel nanostructured lipid car ...... resistance in MCF-7/Adr cells.
@nl
type
label
Novel nanostructured lipid car ...... resistance in MCF-7/Adr cells.
@en
Novel nanostructured lipid car ...... resistance in MCF-7/Adr cells.
@nl
prefLabel
Novel nanostructured lipid car ...... resistance in MCF-7/Adr cells.
@en
Novel nanostructured lipid car ...... resistance in MCF-7/Adr cells.
@nl
P2093
P2860
P1476
Novel nanostructured lipid car ...... resistance in MCF-7/Adr cells.
@en
P2093
Federico Perche
Lucas A M Ferreira
Mônica C Oliveira
Ricardo B Azevedo
Rupa Sawant
Samuel V Mussi
Vladimir P Torchilin
P2860
P304
P356
10.1007/S11095-013-1290-2
P577
2014-02-13T00:00:00Z